Be the first person to write a business review for Apothecary Products, Inc.

Australian Pharmaceutical Industries Limited (API) has developed into one of Australia’s leading beauty and health retail companies. API was founded in 1910 and became one of Australia’s leading pharmaceutical distributors. Changes within the pharmacy industry propelled API to focus on the needs of consumers and patients thereby developing a retail footprint and retail services that provide growth opportunities for the company today. API is one of the leading service providers to the pharmacy industry in Australia and today has a relationship with more than 4000 independent pharmacies. The services include wholesale product delivery, retail services, marketing programs and business advisory services. API also owns and operates the Priceline retail store brand that is a leading health and beauty brand in Australia. The company has product manufacturing capabilities and it is a niche player in over-the-counter pharmaceuticals and toiletries, which supply the Australian and New Zealand markets.API believes that all its service and product offerings must ultimately end with meeting a need of a consumer or patient. As the leading distributor of pharmaceuticals in Australia, API has staff in warehouses across the country that ensure daily deliveries of medicines to pharmacies that aim to improve the life of their patients. API is the leading franchisor in the pharmacy industry, with more than 150 Priceline Pharmacy stores, it provides the pharmacist franchisees a total retail model. Combined with the traditional Priceline stores (no pharmacy service) that the company owns, API provide health and beauty products that meet the needs consumers. Every day staff in these stores are providing advice to consumers to add vitality and wellness to their lives. The manufacture of our products is undertaken to the highest standards so that patients and consumers can benefit from them and improve their lives. API’s story is one of growth and development, and today it continues to pursue growth by supporting its independent pharmacy partners and believes it is best placed to achieve this by focussing on what drives purchasing patterns of health and beauty products.

Axis-Shield plc is a pioneering organisation focused on the development and manufacturing of important in vitro diagnostic tests for use in clinical laboratories and at the point of care. In the laboratory sector we specialise in proprietary markers for diagnosis and management of critical illnesses such as diabetes, cardiovascular and neurodegenerative diseases and rheumatoid arthritis. At the point of care our products include the NycoCard® range and the state-of-the-art Afinion™ system. The company's shares are traded on the London and Oslo Stock Exchanges and the group comprises Laboratory Division in Dundee, a Point-of-Care Division in Oslo with a US operation in Norton, Mass., and local distribution subsidiaries in the UK (Axis-Shield UK), in Norway, Sweden, Denmark and Finland (Medinor), Switzerland (Axis-Shield AG) and in Germany (Axis-Shield GmbH).

Cardinal Health Pharmaceutical is one of the nation's primary pharmaceutical product conveyors. On behalf of its parent, Cardinal Health, the business supplies generic, specialty, and branded prescriptions and OTC products through a distribution network of about 30 facilities located across the US, as well as internationally. It consolidates orders from hundreds of manufacturers into bulk and non-bulk deliveries for health care facilities and retailers. Customers include hospitals, independent pharmacies, and retail chains, including CVS and Walgreen. The division also offers management services and handles inventory, logistics, online procurement, generics sourcing, and other administrative tasks.

Celesio likes being a middleman when it comes to pharmaceuticals. The company is one of Europe's largest drug wholesalers, holding market-leading positions in several of the countries it serves. Its largest wholesale markets are France, Germany, and the UK. In addition to more than 140 wholesale distribution branches, Celesio owns retail chains consisting of 2,300 pharmacies in Europe, including Norway, Italy, and the UK. The company also offers marketing, logistics, and transportation solutions to pharmaceutical manufacturers through its manufacturer solutions division (and its Movianto and pharmexx units). German conglomerate Franz Haniel & Cie. owns a majority stake in Celesio, which was founded in 1835.

CuraScript, Inc. is a wholly owned subsidiary of Express Scripts, Inc., one of the nation’s largest Pharmacy Benefit Managers (PBM’s). As an experienced leader in the specialty pharmacy industry, CuraScript specializes in providing specialty medications and support to individuals with chronic illnesses requiring these complex, high-cost therapies. At CuraScript, we maximize healthcare outcomes while managing the growing costs of biotech medications through industry-leading patient care management programs, patient assistance programs and reimbursement services.Office and clinic-based physicians are the primary customers of our distribution services which provide integrated delivery solutions to safely and consistently distribute pharmaceuticals and medical supplies. CuraScript employs over 2,500 team members and is headquartered in Orlando, Florida. In addition to our state-of-the-art dispensing facility in Orlando, we have a network of satellite distribution pharmacies, including a hemophilia center of excellence, and several infusion centers located across the United States.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.